Published: 2017-05-23

Knowledge, attitudes and practice of adverse drug reaction monitoring among physicians in India

Sukanta Sen, Sk. Rafikul Rahaman, Dattatreyo Chatterjee, Shatavisa Mukherjee, Somnath Mondal, S. K. Tripathi


Background: Underreporting of ADRs still remains a major obstacle in the complete success of pharmacovigilance programs. In order to improve ADR monitoring, it is thus imperative to assess the current knowledge, attitude, and practices of doctors. Therefore, the primary objective of this study was to evaluate the knowledge, attitude, and practices (KAP) of the healthcare professionals about pharmacovigilance in various tertiary care government teaching hospital vis-a-vis private clinics in West Bengal.

Methods: A cross sectional, questionnaire based survey was conducted among healthcare practitioners in several tertiary care government set-ups and private set-ups in the state of West Bengal (India). The study instrument was a pre-validated structured questionnaire designed to obtain information on the knowledge of the ADRs reporting, the attitudes towards the reporting, and the factors that in practice could hinder the reporting among the doctors.

Results: About 89.62% public practitioners correctly spotted the WHO definition for pharmacovigilance, while 77.5% of the private practitioners did the same. Only 19.81% of the public practitioners documented a suspected ADR in any surveillance form, while there were only 3.75% private practitioners who documented it. About 59.43% of the physicians in government hospitals published an ADR case report in any medical journal, while 81.25% private practitioners did no.

Conclusions: Study revealed lack of time, incentive less extra work load being major factors responsible for ADR underreporting. In order to improve ADR reporting, continuous medical education, training and proper sensitization of healthcare professionals can help combating the existing scenario and promising an improved tomorrow. The PvPI should be widely publicized in the visual and print media to make health professionals, as well as the general population at large aware of its presence and scope. Pharmacovigilance should be integrated in undergraduate and postgraduate medical courses.


Attitude, Practice, Adverse ADR monitoring, Drug reaction, Knowledge, Physician, Pharmacovigilance

Full Text:



International drug monitoring: The role of National Centres. Report No: 498. Geneva, Switzerland: World Health Organization; 1972.

Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18820 patients. Br Med J. 2004;329:15-9.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279:1200-5.

The importance of pharmacovigilance. Safety monitoring of medicinal products. Geneva: World Health Organization, WHO Collaborating Centre for International Drug Monitoring; 2002.

Strengthening Pharmaceutical Systems (SPS) Programme. Safety of medicines in Sub-Saharan Africa: Assessment of Pharmacovigilance Systems and their performance. Arlington, VA: 2011;143:4.

Gala KS, Sinha SR, Mankeshwar R, Desai VK, Gala RS. Evaluation of the pattern of self-medication among the paramedical support staff in a tertiary care hospital. J Young Pharm. 2016;8(1):23-7.

Remesh A. Identifying the reasons for under reporting of ADR: A cross sectional survey. Res J Pharm Biol Chem Sci. 2012;3:1379-86.

Ramesh M, Pandit J, Parthasarathi G, Adverse drug reactions in south Indian hospital-their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12(8):687-92.

Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Googtay NJ, Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the Medical emergency department of tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007;7(1):1-5.

Ratan JL, Mangala L. An update on the Pharmacovigilance Programme of India. Front Pharmacol. 2015;6:194. Available from: Pharmacovigilance_Programme_of_India

Gupta SK, Text book of pharmacovigilance: Current Methods of Pharmacovigilance. New Delhi: Jaypee brothers Medical Publisher (P) Ltd; 2011:28-38.

Ganesan S, Vikneswaran G, Reddy KC, Subrahmanyam DK, Adithan C. A Survey on Knowledge, Attitude and Practice of Pharmacovigilance towards Adverse drug reactions reporting among Doctors and Nurses in a Tertiary Care Hospital in South India. J Young Pharm. 2016;8(4):471-6.

Malhotra S, Karan RS, Pandhi P, Jain S. Drug related medical emergencies in the elderly: Role of adverse drug reactions and non-compliance. Postgrad Med J. 2001;77:703-7.

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2:129-36.

Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: Knowledge, attitude and practices of medical students and prescribers. Natl Med J India. 2002;15:24-6.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: knowledge, attitude and perception among resident doctors. J Pharm Sci. 2011;3:1064-9.

ASHP guidelines on adverse drug reaction monitoring and reporting. American Society of Hospital Pharmacy. Am J Health Syst Pharm 1995 Feb 15;52(4):417-9.

Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reactions in a hospital general medical unit meriting notification to committee on safety of medicines. Br J Clin Pharmacol. 1996;42:423-9.

Biswas P. Pharmacovigilance in Asia. J Pharmacol Pharmacother. 2013;4(1):S7-19.

Rishi RK, Patel RK, Bhandari A. Opinion of physicians towards adverse drug reaction reporting results of pilot study. Journal of Community Medicine and Health. 2012;1:25-9.

Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. J Nat Sci Biol Med. 2013 Jan-Jun;4(1):191-6.

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47:65-71.

Rishi RK, Patel RK, Bhandari A. Under reporting of ADRs by Medical Practitioner in India- Results of pilot study. Adv Pharmacoepidem Drug Saf. 2012;1(3):1-3.

Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich SN, Ostermann T, et al. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health. 2009;9:274.

Pimpalkhute SA, Jaiswal KM, Sontakke SD, Bajait CS, Gaikwad A. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian J Med Sci. 2012;66:55-61.

Reddy P, Varma SK, Reddy S. Knowledge, attitude and practice of ADR reporting among clinical residents: A rural medical college survey. J Drug Discov Ther. 2014;2:8-13.

Chatterjee S, Lyle N, Ghosh S. A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India. Drug Saf. 2006;29:641-2.

Datta S, Sengupta S. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting in a tertiary care teaching hospital of Sikkim. Perspectives in Clinical Research. 2015;6(4):200-6.

Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res. 1997;35:85-8.

Figueiras A, Herdeiro MT, Polónia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: A cluster-randomized controlled trial. JAMA. 2006;296:1086-93.

Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspectives in Clinical Research. 2015;6(1):45-52.

Santosh KC, Pramote T, Gorsanan S, Edwards R. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC Pharmacol Toxicol. 2013;14(1):14-6.

Kira LJ, Shivashankaramurthy KG, Bhooma S, Dinakar KR. Adverse drug reactions reporting among clinician in a teaching hospital South Karnataka. Sch J App Med Sci. 2014;2(1D):399-403.

McGettigan P, Feely J. ADR reporting: Opinion and attitudes of medical practitioners in Ireland. Pharmacoepidemiol Drug Saf. 1995;4:355-8.

Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J. 2004;117:856-61.

Upadhyaya HB, Vora MB, Nagar JG, Patel PB. Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of tertiary care hospital in Gujarat. J Adv Pharm Technol Res. 2015;6(1):29-34.

Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero J. Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2005;28(9):825-33.

Rajesh R, Vidyasagar S, Varma DM. An educational intervention to assess knowledge, Attitude, practice of pharmacovigilance among healthcare professional in an Indian tertiary care teaching hospital. Int J Pharm Tech Res. 2011;3(2):678-92.

Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists' attitudes on adverse drug reaction reporting: A case-control study in Portugal. Drug Saf. 2006;29:331-40.

Klopotowska JE, Wierenga PC, Smorenburg SM, Stuijt CC, Arisz L, Kuks PF, et al. Recognition of adverse drug events in older hospitalized medical patients. Eur J Clin Pharmacol. 2013;69:75-85.

Chopra D, Wardhan N, Rehan HS. Knowledge, attitude and practices associated with adverse drug reaction reporting amongstdoctors in a teaching hospital. Int J Risk Saf Med. 2011;23(4):227-32.